The MDS 3.0 I1500 measure demonstrated fair agreement, low sensitivity, and high specificity for identifying kidney impairment compared with eGFR values. Cross-referencing federally mandated MDS data with eGFR data could improve kidney impairment identification and care planning in NHs.
Radjabova et al. (Fri,) studied this question.